Neu Hc
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
- Pharmacology 20
- Antibiotics Pharmacokinetics and Efficacy 17
-
- Antibiotic Resistance in Bacteria 16
- Co-authors
- David E. Fleischer (1 shared paper)J. Winter (2 shared papers)P Labthavikul (2 shared papers)Charles E. Cherubin (1 shared paper)R.C. Steinman (2 shared papers)SE Hickman (1 shared paper)P Aswapokee (1 shared paper)Dalia Cohen (1 shared paper)
- Journals
- The American Journal of Medicine (2 papers)PubMed (39 papers)
- Partner nations
- United States
In The Last Decade
Neu Hc
38 papers receiving 461 citations
Peers
Comparison fields: 5 of 80
- Molecular Medicine 203
- Applied Microbiology and Biotechnology 30
- Pharmacology 258
- Clinical Biochemistry 49
- Ophthalmology 51
Countries citing papers authored by Neu Hc
This map shows the geographic impact of Neu Hc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neu Hc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neu Hc more than expected).
Fields of papers citing papers by Neu Hc
This network shows the impact of papers produced by Neu Hc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neu Hc. The network helps show where Neu Hc may publish in the future.
Co-authors
The 9 scholars most cited alongside Neu Hc, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ciprofloxacin: an overview and prospective appraisal. | 1987 | 77 |
| 2 | Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria. | 1987 | 61 |
| 3 | Cefotaxime and desacetylcefotaxime: an example of advantageous antimicrobial metabolism. | 1984 | 51 |
| 4 | Microbiologic aspects of fluoroquinolones. | 1991 | 49 |
| 5 | Treatment of serious infections with intravenous ciprofloxacin. | 1987 | 33 |
| 6 | In vitro studies of a semisynthetic penicillin, 6-(D(-)- -carboxy-3-thienylacetamido) penicillanic acid (BRL 2288), active against Pseudomonas. | 1970 | 30 |
| 7 | The pharmacokinetics of new cephalosporins: significance in clinical practice. | 1984 | 20 |
| 8 | Chemical evolution of the fluoroquinolone antimicrobial agents. | 1989 | 19 |
| 9 | Controversies, dilemmas, and dialogues. Recommendations for antibiotic prophylaxis before endoscopy. | 1989 | 17 |
| 10 | Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams. | 1987 | 16 |
| 11 | Antibiotic resistance of Salmonella in the eastern United States. | 1969 | 12 |
| 12 | Effect of human lysozyme on gram-positive and gram-negative bacteria. | 1968 | 11 |
| 13 | Penicillins--new insights into their mechanisms of activity and clinical use. | 1982 | 10 |
| 14 | A symposium on the tetracyclines: a major appraisal. Introduction. | 1978 | 9 |
| 15 | Probenecid-resistant J774 cell expression of enhanced organic anion transport by a mechanism distinct from multidrug resistance. | 1993 | 9 |
| 16 | Antibiotic resistance of salmonella in northeastern United States 1968-199. | 1971 | 9 |
| 17 | -lactamase production by Pseudomonas aeruginosa. | 1970 | 9 |
| 18 | Adult Hemophilus influenzae meningitis; associated with disseminated intravascular coagulation. | 1969 | 8 |
| 19 | In vitro activity of pefloxacin compared to that of quinolones and other antimicrobial agents. | 1984 | 7 |
| 20 | A perspective on the present contribution of beta-lactamases to bacterial resistance with particular reference to induction of beta-lactamase and its clinical significance. | 1985 | 7 |
About Neu Hc
Neu Hc is a scholar working on Pharmacology, Molecular Medicine, Infectious Diseases, Applied Microbiology and Biotechnology and Molecular Biology, having authored 41 papers that have together received 519 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Antibiotic Resistance in Bacteria (16 papers), Antibiotic Use and Resistance (5 papers), Bacterial Identification and Susceptibility Testing (4 papers), Infectious Diseases and Tuberculosis (3 papers), Pharmaceutical studies and practices (3 papers), Pneumonia and Respiratory Infections (2 papers) and Salmonella and Campylobacter epidemiology (2 papers). The work is most often cited by research in Molecular Medicine (203 citations), Applied Microbiology and Biotechnology (30 citations), Pharmacology (258 citations), Clinical Biochemistry (49 citations) and Ophthalmology (51 citations). Neu Hc has collaborated with scholars based in United States. Frequent co-authors include David E. Fleischer, J. Winter, P Labthavikul, Charles E. Cherubin, R.C. Steinman, SE Hickman, P Aswapokee, Dalia Cohen and Nalinee Aswapokee. Their work appears in journals such as The American Journal of Medicine and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.